Publications list for Professor Richard Christopherson

2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Mactier, S., Kaufman, K., Wang, P., Crossett, B., Pupo, G., Kohnke, P., Thompson, J., Scolyer, R., Yang, J., Mann, G., Christopherson, R. (2014), Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients. Pigment Cell & Melanoma Research. 27(6), 1106-1116. [Abstract]
  • Chik, J., Zhou, J., Moh, E., Christopherson, R., Clarke, S., Molloy, M., Packer, N. (2014), Comprehensive glycomics comparison between colon cancer cell cultures and tumours: Implications for biomarker studies. Journal of Proteomics. 108(C), 146-162. [Abstract]
  • Christopherson, R., Mactier, S., Almazi, J., Kohnke, P., Best, O., Mulligan, S. (2014), Mechanisms of Action of Fludarabine Nucleoside Against Human Raji Lymphoma Cells. Nucleosides, Nucleotides & Nucleic Acids. 33(4-6), 375-383. [Abstract]
  • Huang, P., Best, O., Almazi, J., Belov, L., Davis, Z., Majid, A., Dyer, M., Pascovici, D., Mulligan, S., Christopherson, R. (2014), Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia. Leukemia & Lymphoma. 55(9), 2085-2092. [Abstract]
  • Kaufman, K., Mactier, S., Armstrong, N., Mallawaaratchy, D., Byrne, S., Haydu, L., Jakrot, V., Thompson, J., Mann, G., Scolyer, R., Christopherson, R. (2014), Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients. Clinical & Experimental Metastasis. 31, 407-421. [Abstract]
  • Alomari, M., Mactier, S., Kaufman, K., Best, O., Mulligan, S., Christopherson, R. (2014), Profiling the lipid raft proteome from human MEC1 chronic lymphocytic Leukemia Cells. Journal of Proteomics and Bioinformatics. 7(4), 005.


  • Che, Y., Best, O., Zhong, L., Kaufman, K., Mactier, S., Raftery, M., Graves, L., Mulligan, S., Christopherson, R. (2013), Hsp90 inhibitor snx-7081 dysregulates proteins involved with dna repair and replication and the cell cycle in human chronic lymphocytic leukemia (cll) cells. Journal of Proteome Research. 12(4), 1710-1722. [Abstract]
  • Huang, P., Kohnke, P., Belov, L., Best, G., Mulligan, S., Christopherson, R. (2013), Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes. Journal of Pharmacy & Pharmaceutical Sciences. 16(2), 231-237. [Abstract]
  • Cooper, M., Cox, N., Zimmerman, E., Dewar, B., Duncan, J., Whittle, M., Nguyen, T., Jones, L., Ghose Roy, S., Smalley, D., Kuan, P., Richards, K., Christopherson, R., Jin, J., Frye, S., Johnson, G., Baldwin, A., Graves, L. (2013), Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia. PloS One. 8(6), e66755. [Abstract]


  • Kohnke, P., Mactier, S., Almazi, J., Crossett, B., Christopherson, R. (2012), Fludarabine and Cladribine Induce Changes in Surface Proteins on Human B-Lymphoid Cell Lines Involved with Apoptosis, Cell Survival, and Antitumor Immunity. Journal of Proteome Research. 11(9), 4436-4448. [Abstract]
  • Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012), Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International. 32(10), 1527-1534. [Abstract]
  • Leong, S., Nunez, A., Lin, M., Crossett, B., Christopherson, R., Baxter, R. (2012), iTRAQ-Based Proteomic Profiling of Breast Cancer Cell Response to Doxorubicin and TRAIL. Journal of Proteome Research. 11(7), 3561-3572. [Abstract]
  • Huang, P., Giles Best, O., Belov, L., Mulligan, S., Christopherson, R. (2012), Surface profiles for sub-classification of chronic lymphocytic leukemia. Leukemia and Lymphoma. 53(6), 1046-1056. [Abstract]
  • Almazi, J., Mactier, S., Best, O., Crossett, B., Mulligan, S., Christopherson, R. (2012), Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53. Proteomics - Clinical Applications. 6(5-6), 279-290. [Abstract]
  • Mallawaaratchy, D., Mactier, S., Kaufman, K., Blomfield, K., Christopherson, R. (2012), The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells. Journal of proteomics. 75(5), 1590-9. [Abstract]
  • Leong, S., McKay, M., Christopherson, R., Baxter, R. (2012), Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. Journal of proteome research. 11(2), 1240-50. [Abstract]
  • Best, O., Che, Y., Singh, N., Forsyth, C., Christopherson, R., Mulligan, S. (2012), The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. Leukemia & Lymphoma. 53(7), 1367-1375. [Abstract]


  • Henrich, S., Mactier, S., Best, G., Mulligan, S., Crossett, B., Christopherson, R. (2011), Fludarabine nucleoside modulates nuclear "survival and death" proteins in resistant chronic lymphocytic leukemia cells. Nucleosides, Nucleotides and Nucleic Acids. 30(12), 1181-1189. [Abstract]
  • Mactier, S., Henrich, S., Che, Y., Kohnke, P., Christopherson, R. (2011), Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. Journal of Proteome Research. 10(3), 1030-1042. [Abstract]
  • Heath, E., Kaufman, K., Christopherson, R. (2011), B-RAF: A Contributor to the Melanoma Phenotype. The international journal of biochemistry & cell biology. 43(1), 29-32. [Abstract]
  • Zhou, J., Belov, L., Solomon, M., Chan, C., Clarke, S., Christopherson, R. (2011), Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing. Journal of Visualized Experiments. 0(55), 3322. [Abstract]


  • Yang, F., Tay, K., Dong, L., Thorne, R., Jiang, C., Yang, E., Tseng, H., Liu, H., Christopherson, R., Hersey, P., Zhang, X. (2010), Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death and Differentiation. 17(8), 1354-1367. [Abstract]
  • Kaufman, K., Belov, L., Huang, P., Mactier, S., Scolyer, R., Mann, G., Christopherson, R. (2010), An extended antibody microarray for surface profiling metastatic melanoma. Journal of immunological methods. 358(1-2), 23-34. [Abstract]
  • Zhou, J., Belov, L., Huang, P., Shin, J., Solomon, M., Chapuis, P., Bokey, L., Chan, C., Clarke, C., Clarke, S., Christopherson, R. (2010), Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. Journal of Immunological Methods. 355(1-2), 40-51. [Abstract]
  • Belov, L., Zhou, J., Christopherson, R. (2010), Cell surface markers in colorectal cancer prognosis. International journal of molecular sciences. 12(1), 78-113. [Abstract]
  • Cassano, J., Mactier, S., Mulligan, S., Belov, L., Huang, P., Christopherson, R. (2010), Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. International Journal of Proteomics. 2010, 964251.


  • Kohnke, P., Mulligan, S., Christopherson, R. (2009), Membrane proteomics for leukemia classification and drug target identification. Current Opinion in Molecular Therapeutics. 11(6), 603-610. [Abstract]
  • Barber, N., Gez, S., Belov, L., Mulligan, S., Woolfson, A., Christopherson, R. (2009), Profiling CD antigens on leukaemias with an antibody microarray. FEBS Letters. , 1785-1791. [Abstract]
  • Langley, D., Shojaei, M., Chan, C., Lok, H., Mackay, J., Traut, T., Guss, J., Christopherson, R. (2009), Structure and Inhibition of Orotidine 5'-Monophosphate Decarboxylase from Plasmodium falciparum. Biochemistry. 48(11), 2570. [Abstract]